A case of carbamazepine (Tegretol®) poisoning is presented. The symptoms and signs were surprisingly severe after ingestion of only JOg. Treatment and unusual features of the case are discussed.
Carbamazepine is absorbed rapidly from the gastro-intestinal canal and is partly bound to the plasma proteins. Biotransformation takes place in the liver, and only a minor fraction is excreted unchanged in the urine.
The recommended daily dose varies from 200-1200 mg in the treatment of trigeminal neuralgia and epilepsy. After oral intake of an overdose the first symptoms appear after 1-3 hours; these include various neuromuscular and cardiovascular disturbances. The most prominent features of acute poisoning are restlessness, tremor, ataxia and psychotic behaviour, coma, shallow respiration progressing to respiratory arrest, low blood pressure and tachycardia. The electrocardiograph (ECG) may show a variety of conduction disorders. Despite the increasing use of carbamazepine only a few reports of deliberate self-poisoning have been published and all the serious intoxications have been after ingestion of doses exceeding 20 g.4,5 A severe case of acute poisoning after a relatively small dose of carbamazepine is presented.
CASE HISTORY A 26-year-old man was brought to the acute receiving room after attempted suicide. On arrival he was drowsy, but able to explain that six hours previously he had ingested 50 tablets of Tegretol ® (a total dose of 109 carbamazepine) and 10 tablets of an analgesic containing a total of 2.5 g acetylsalicylic acid and 2.5 g phenacetin. The amount of drugs taken was confirmed by the patient after recovery.
The respiration was described as insufficient during the transportation to the hospital, but at arrival it seemed sufficient with no cyanosis. Systolic blood pressure was 150 mm Hg and pulse rate 100 beats per min. ECG showed sinus rhythm with prolongation of the QRS interval (0.12 sec.). The stomach was emptied by a wide bore stomach tube but the aspirate showed no sign of tablets. Thereafter, it was decided to transfer the patient to the intensive therapy unit. At this stage the patient suddenly became stuporous with minor convulsions, chorea-like movements and nystagmus. Respiration became quite inadequate and cyanosis was apparent. A nasotracheal tube was passed and artificial ventilation with an Elema-Servo ventilator was instituted. Blood samples were taken for determination of carbamazepine, acetylsalicylic acid, sodium, potassium, creatinine, glucose, hemoglobin and arterial blood gases. Forced diuresis and alkalinisation of the urine was commenced.
Two hours after the patient's admission, however, the laboratory reported that the serum level of acetylsalicylic acid was less than 0.2 mmolll, so the forced diuresis was stopped.
The patient was kept sedated and relaxed with d-tubocurarine to facilitate hyperventilation and abolish convulsions. The PaCO, was maintained at 22 mmHg (3 kPa) and PaO, at 100 mmHg (13.3 kPa). The ECG was monitored continuously and showed no significant arrhythmias, and the duration of the QRS complex returned to normal. The blood pressure and pulse rate remained constant throughout the period of observation.
On the second day the patient developed a raised level of serum bilirubin, reaching a maximum of 24 mmolll, while the plasma hemoglobin was 205 J.imolll. No renal complications developed as a result of the hemolysis. The blood concentration of carbamazepine on arrival was found to be greater than 200 J.imolll.
No further signs of intoxication developed and the patient was transferred to the psychiatric ward after 88 hours in the intensive therapy unit.
DISCUSSION
Only relatively few cases of carbamazepine intoxication have so far been published. The drug is generally considered relatively nontoxic with a high therapeutic index. 6 When prescribing carbamazepine, it is advisable to start on a low dose and to slowly increase up to the necessary therapeutic level in order to avoid side effects.
In this case a life-threatening intoxication appeared after the ingestion of a relatively small dose of 50 tablets equivalent to 10 g. As already mentioned the side effects are more frequent and more severe after abrupt initiation of the treatment. A possible explanation for the severe symptoms seen in our patient is that he was not already on continuous carbamazepine treatment at the time of the suicidal attempt.
Because of the respiratory insufficiency the patient was artificially ventilated. The chemical resemblance between carbamazepine and the tricyclic antidepressants persuaded us to choose hyperventilation, as recommended in the treatment of poisoning with the latter. 7. 8 The haemolysis from the second to the fourth day may be interpreted as a new and unknown side effect of carbamazepine or as a result of the concomitant phenacetin medication. Unfortunately no further laboratory investigations were carried out to elucidate this.
In spite of widespread use of carbamazepine, surprisingly few cases of acute poisoning have been reported. Our patient was prescribed the drug because of atypical neuralgia in the upper extremity.
This case history stresses the need for careful evaluation of the patient and his symptoms before prescribing new medication, and for careful observation of the patient after admission to hospital.
